title: Natriuretic and vasoactive hormones and glomerular hyperfiltration in hyperglycaemic type 2 diabetic patients: effect of insulin treatment.
abstract: Evidence that an increase in plasma atrial natriuretic peptide (ANP) concentrations mediates, at least in part, glomerular hyperfiltration in diabetic rats prompted us to study the relationship between ANP and renal haemodynamics in hyperfiltering type 2 diabetic patients in association with other hormones implicated in the control of glomerular filtration rate (GFR) (catecholamines, vasopressin, renin) and in sodium tubular transport (aldosterone, ouabain-displacing factor, ODF). Since hyperglycaemia is also associated to hyperfiltration, diabetic patients who presented with secondary drug failure were studied both in hyperglycaemic and in normoglycaemic condition. For this purpose, 11 normotensive non-macroproteinuric hyperfiltering patients with type 2 diabetes were treated with an 8-day continuous insulin infusion (days 0-7). Dehydration was prevented or corrected and natriuresis was on day 0 above 100 mmol/day. The following parameters were determined on days 0 and 7: GFR and renal plasma flow (RPF) by 99mTc-DTPA and 131I-hippuran clearances; the extracellular volume, assimilated to the DTPA diffusion volume; urinary ODF by receptor-binding assay and urinary as well as plasma catecholamines by HPLC after extraction on alumin. Plasma ANP and antidiuretic hormone (ADH) were measured by radioimmunoassay after extraction on phenyl-silylsilica (ANP) and with ether (ADH). Unextracted plasma was used for radioimmunological measurement of plasma renin activity and aldosterone. When correcting hyperglycaemia to normoglycaemia GFR decreased from high to normal mean value (138 +/- 27 and 115 +/- 6 ml/min, p < 0.001), RPF followed the same trend, and the DTPA diffusion volume did not change.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Section of Endocrinology, Hôpital Sud, Amiens, France.
authors.forename: J D
authors.initials: JD
authors.lastname: Lalau
authors.forename: P F
authors.initials: PF
authors.lastname: Westeel
authors.forename: F
authors.initials: F
authors.lastname: Tenenbaum
authors.forename: X
authors.initials: X
authors.lastname: Debussche
authors.forename: J
authors.initials: J
authors.lastname: Nussberger
authors.forename: B
authors.initials: B
authors.lastname: Tribout
authors.forename: P
authors.initials: P
authors.lastname: Fardelonne
authors.forename: H
authors.initials: H
authors.lastname: Favre
authors.forename: A
authors.initials: A
authors.lastname: Fournier
mesh_terms: D000328:Adult; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D005919:Glomerular Filtration Rate; D006728:Hormones / Q000097:blood; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012079:Renal Circulation; D014667:Vasopressins / Q000097:blood
chemical_list: D006728:Hormones; D007328:Insulin; D014667:Vasopressins; D009320:Atrial Natriuretic Factor